Reposar, Jhon Rey B.
HRN: 07-39-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFTAZIDIME 1GM (VIAL)
02/15/2023
02/17/2023
IV
1 Gram
Q8
T/C Sepsisi
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes